Craig-Hallum initiated coverage of Maravai Lifesciences with a Buy rating and $15 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRVI:
- Applied DNA Sciences enters manufacturing agreement with Alphazyme
- Maravai LifeSciences Announces March 2024 Investor Conference Schedule
- Maravai LifeSciences trading resumes
- Maravai LifeSciences trading halted, volatility trading pause
- Maravai Lifesciences price target lowered to $10 from $11 at Stifel